Quarterly report pursuant to Section 13 or 15(d)

Stock Based Compensation (Details)

v3.20.2
Stock Based Compensation (Details)
 9 Months Ended
Sep. 30, 2020
USD ($)
$ / shares
shares
Number of shares  
Number of shares, Beginning balance | shares 12,553,326
Number of shares, Grants | shares 2,250,000
Number of shares, Expiration | shares (758,500)
Number of shares, Ending balance | shares 14,044,826
Options exercisable, Ending balance | shares 13,919,826
Weighted Average Exercise Price  
Weighted Average Exercise Price, Beginning balance | $ / shares $ 0.55
Weighted Average Exercise Price, Grants | $ / shares 0.19
Weighted Average Exercise Price, Expiration | $ / shares 0.68
Weighted Average Exercise Price, Ending balance | $ / shares 0.48
Options exercisable, Ending balance | $ / shares $ 0.49
Weighted Average Remaining Contractual Life (years)  
Weighted Average Remaining Contractual Life (years), Beginning balance 4 years 7 days
Weighted Average Remaining Contractual Life (years), Grants 4 years 9 months 7 days
Weighted Average Remaining Contractual Life (years), Expiration
Weighted Average Remaining Contractual Life (years), Ending balance 3 years 7 months 6 days
Options exercisable, Ending balance 3 years 7 months 2 days
Aggregate Intrinsic Value  
Aggregate Intrinsic Value, Beginning balance | $ $ 927
Aggregate Intrinsic Value, Ending balance | $ 843,586
Options exercisable, Ending balance, Intrinsic value | $ $ 823,586